IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Saroja Pharma Industries India IPO offer price is ₹ 84.00 and got listed at ₹ 68.25. Read IPO details mentioned above.
Saroja Pharma Industries India IPO listing price is ₹ 68.25, issue price is ₹ 84.00, and currently trading at ₹ 38.65 as on 5 march 2025. Infraprime Logistics IPO performance is show below with lates CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Saroja Pharma Industries India IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Chemical - Speciality sector. Swastika Investmart is the merchant banker of Saroja Pharma Industries India IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 15th June 2023.
Saroja Pharma Industries India IPO offer price is ₹ 84.00 and got listed at ₹ 68.25. Read Infraprime Logistics Technologies IPO details mentioned above.Listing Gain
Issue Price vs Listing Price:Market Performance
Issue Price vs CMP:Saroja Pharma Industries India IPO, based in Mumbai, operates in the Chemical - Speciality sector with a focus on Pharmaceutical and healthcare. The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Saroja Pharma Industries India IPO size is ₹ 9.11 Cr. Crores with fresh issue size of Rs 9.11 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Saroja Pharma Industries India IPO is expected to be 8th September 2023, after the finalization of basis of allotment. Investors can check Saroja Pharma Industries India IPO allotment status on the registrars website, Kfin Technologies Limited. Saroja Pharma Industries India IPO refund dates are 11th September 2023.
Saroja Pharma Industries India IPO is expected to be listed on 13th September 2023.
The upper price band for the Saroja Pharma Industries India IPO is set at ₹ 84.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Saroja Pharma Industries India IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Saroja Pharma Industries India IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 5th September 2023. After submission, funds are blocked until the basis of allotment of Saroja Pharma Industries India IPO is finalised.
The merchant banker for Saroja Pharma Industries India IPO is Swastika Investmart Limited . Swastika Investmart Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Saroja Pharma Industries India IPO RHP for further details.
The registrar for Saroja Pharma Industries India IPO is Kfin Technologies Limited. Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Saroja Pharma Industries India IPO through their official website or helpline.
Saroja Pharma Industries India IPO was subscribed 8.88 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Saroja Pharma Industries India IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Saroja Pharma Industries India Financial Review Page
Merchant Banker(s) of Saroja Pharma Industries India IPO: Swastika Investmart Limited
Saroja Pharma Industries India IPO subscription was 8.88 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Saroja Pharma Industries India IPO listed at a listing price of 68.25 against the offer price of 84.00.
The current market price of Saroja Pharma Industries India is 38.65.
Why Us?
